郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A target affinity enrichment workflow to characterize critical post-translational modifications within therapeutic antibodies.

期刊：Journal of pharmaceutical sciences发表年份：2025作者：Jethro E Prinston; Wenjing Peng; Kathleen Provoncha; Youmi Moon; Evan Koufos; Cristinel Sandu; Yue Fu; Yuetian Yan; Shunhai Wang; Ning Li; Jennifer B Nguyen; Michael P Rosconi; Erica A Pyles
阅读更多 →

药效评价Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity.

期刊：Archives of toxicology发表年份：2025作者：Manuela Carla Monti; Tobias Rautio; Marie H Deventer; Markus Schläpfer; Johannes Tveit; Alex J Krotulski; Victoria Marland; Robert Reid; Niamh Nic Daeid; Craig McKenzie; Christophe P Stove; Henrik Green; Caitlyn Norman
阅读更多 →

药效评价IDOR-1104-0086, a novel Kv7 channel activator with antiseizure effects in rodents.

期刊：Neuropharmacology发表年份：2025作者：Melanie Kessler; Andreas Mühlemann; Malgorzata Anna Mis; Romain Siegrist; Swen Seeland; Caroline Deymier; Cary-Ann Mathieu; Hélène Roellinger; Tsvetomira Atanasova; Catherine Roch; Michel Alexander Steiner
阅读更多 →

药效评价Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assay.

期刊：Biochemical pharmacology发表年份：2025作者：Wenqin Xu; Abigail M Keith; Wenjuan Ye; Xin Hu; Noel Southall; Juan J Marugan; Marc Ferrer; Mark J Henderson; Patrick M Sexton; Giuseppe Deganutti; Lee E Eiden
阅读更多 →